Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 562 entries
Sorted by: Best Match Show Resources per page
Monitoring Alpha Oscillations and Pupil Dilation across a Performance-Intensity Function.

Frontiers in psychology

McMahon CM, Boisvert I, de Lissa P, Granger L, Ibrahim R, Lo CY, Miles K, Graham PL.
PMID: 27252671
Front Psychol. 2016 May 24;7:745. doi: 10.3389/fpsyg.2016.00745. eCollection 2016.

Listening to degraded speech can be challenging and requires a continuous investment of cognitive resources, which is more challenging for those with hearing loss. However, while alpha power (8-12 Hz) and pupil dilation have been suggested as objective correlates...

Cite
McMahon CM, Boisvert I, de Lissa P, et al. Monitoring Alpha Oscillations and Pupil Dilation across a Performance-Intensity Function. Front Psychol. 2016;7:745doi: 10.3389/fpsyg.2016.00745.
McMahon, C. M., Boisvert, I., de Lissa, P., Granger, L., Ibrahim, R., Lo, C. Y., Miles, K., & Graham, P. L. (2016). Monitoring Alpha Oscillations and Pupil Dilation across a Performance-Intensity Function. Frontiers in psychology, 7745. https://doi.org/10.3389/fpsyg.2016.00745
McMahon, Catherine M, et al. "Monitoring Alpha Oscillations and Pupil Dilation across a Performance-Intensity Function." Frontiers in psychology vol. 7 (2016): 745. doi: https://doi.org/10.3389/fpsyg.2016.00745
McMahon CM, Boisvert I, de Lissa P, Granger L, Ibrahim R, Lo CY, Miles K, Graham PL. Monitoring Alpha Oscillations and Pupil Dilation across a Performance-Intensity Function. Front Psychol. 2016 May 24;7:745. doi: 10.3389/fpsyg.2016.00745. eCollection 2016. PMID: 27252671; PMCID: PMC4877370.
Copy Download .nbib Format: NLM
Landau-Zener-Stückelberg Interferometry in Quantum Dots with Fast Rise Times: Evidence for Coherent Phonon Driving.

Physical review letters

Korkusinski M, Studenikin SA, Aers G, Granger G, Kam A, Sachrajda AS.
PMID: 28234547
Phys Rev Lett. 2017 Feb 10;118(6):067701. doi: 10.1103/PhysRevLett.118.067701. Epub 2017 Feb 08.

Manipulating qubits via electrical pulses in a piezoelectric material such as GaAs can be expected to generate incidental acoustic phonons. In this Letter we determine theoretically and experimentally the consequences of these phonons for semiconductor spin qubits using Landau-Zener-Stückelberg...

Cite
Korkusinski M, Studenikin SA, Aers G, et al. Landau-Zener-Stückelberg Interferometry in Quantum Dots with Fast Rise Times: Evidence for Coherent Phonon Driving. Phys Rev Lett. 2017;118(6):067701doi: 10.1103/PhysRevLett.118.067701.
Korkusinski, M., Studenikin, S. A., Aers, G., Granger, G., Kam, A., & Sachrajda, A. S. (2017). Landau-Zener-Stückelberg Interferometry in Quantum Dots with Fast Rise Times: Evidence for Coherent Phonon Driving. Physical review letters, 118(6), 067701. https://doi.org/10.1103/PhysRevLett.118.067701
Korkusinski, M, et al. "Landau-Zener-Stückelberg Interferometry in Quantum Dots with Fast Rise Times: Evidence for Coherent Phonon Driving." Physical review letters vol. 118,6 (2017): 067701. doi: https://doi.org/10.1103/PhysRevLett.118.067701
Korkusinski M, Studenikin SA, Aers G, Granger G, Kam A, Sachrajda AS. Landau-Zener-Stückelberg Interferometry in Quantum Dots with Fast Rise Times: Evidence for Coherent Phonon Driving. Phys Rev Lett. 2017 Feb 10;118(6):067701. doi: 10.1103/PhysRevLett.118.067701. Epub 2017 Feb 08. PMID: 28234547.
Copy Download .nbib Format: NLM
OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?.

Thrombosis research

Faille D, Ajzenberg N, de Chaisemartin L, Granger V, Chollet-Martin S, de Raucourt E, Hammel P, Lévy P, Ruszniewski P, Rebours V.
PMID: 27161678
Thromb Res. 2016 Apr;140:S170-1. doi: 10.1016/S0049-3848(16)30123-2. Epub 2016 Apr 08.

INTRODUCTION: Venous thrombo-embolic events (VTE) occur frequently in patients with pancreatic cancer and contribute to elevated morbidity and mortality. Clinical risk factors for thrombosis such as cancer stage and tumor grade have been clearly identified. Recently, several biomarkers have...

Cite
Faille D, Ajzenberg N, de Chaisemartin L, et al. OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?. Thromb Res. 2016;140:S170-1doi: 10.1016/S0049-3848(16)30123-2.
Faille, D., Ajzenberg, N., de Chaisemartin, L., Granger, V., Chollet-Martin, S., de Raucourt, E., Hammel, P., Lévy, P., Ruszniewski, P., & Rebours, V. (2016). OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?. Thrombosis research, 140S170-1. https://doi.org/10.1016/S0049-3848(16)30123-2
Faille, D, et al. "OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?." Thrombosis research vol. 140 (2016): S170-1. doi: https://doi.org/10.1016/S0049-3848(16)30123-2
Faille D, Ajzenberg N, de Chaisemartin L, Granger V, Chollet-Martin S, de Raucourt E, Hammel P, Lévy P, Ruszniewski P, Rebours V. OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?. Thromb Res. 2016 Apr;140:S170-1. doi: 10.1016/S0049-3848(16)30123-2. Epub 2016 Apr 08. PMID: 27161678.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Seisen T, Granger B, Colin P, Léon P, Utard G, Renard Penna R, Compérat E, Mozer P, Cussenot O, Shariat S, Rouprêt M.
PMID: 26544373
Prog Urol. 2015 Nov;25(13):805. doi: 10.1016/j.purol.2015.08.178.

No abstract available.

Cite
Seisen T, Granger B, Colin P, et al. Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d'une tumeur de la voie excrétrice urinaire supérieure. [Not Available]. Prog Urol. 2015;25(13):805doi: 10.1016/j.purol.2015.08.178.
Seisen, T., Granger, B., Colin, P., Léon, P., Utard, G., Renard Penna, R., Compérat, E., Mozer, P., Cussenot, O., Shariat, S., & Rouprêt, M. (2015). Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d'une tumeur de la voie excrétrice urinaire supérieure. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 805. https://doi.org/10.1016/j.purol.2015.08.178
Seisen, T, et al. "Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d'une tumeur de la voie excrétrice urinaire supérieure." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 805. doi: https://doi.org/10.1016/j.purol.2015.08.178
Seisen T, Granger B, Colin P, Léon P, Utard G, Renard Penna R, Compérat E, Mozer P, Cussenot O, Shariat S, Rouprêt M. Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d'une tumeur de la voie excrétrice urinaire supérieure. [Not Available]. Prog Urol. 2015 Nov;25(13):805. doi: 10.1016/j.purol.2015.08.178. French. PMID: 26544373.
Copy Download .nbib Format: NLM
Assessing generalizability of trial results in general practice.

European heart journal

Pokorney SD, O'Brien EC, Granger CB.
PMID: 26516173
Eur Heart J. 2016 Apr 07;37(14):1154-7. doi: 10.1093/eurheartj/ehv532. Epub 2015 Oct 29.

No abstract available.

Cite
Pokorney SD, O'Brien EC, Granger CB. Assessing generalizability of trial results in general practice. Eur Heart J. 2015;37(14):1154-7doi: 10.1093/eurheartj/ehv532.
Pokorney, S. D., O'Brien, E. C., & Granger, C. B. (2016). Assessing generalizability of trial results in general practice. European heart journal, 37(14), 1154-7. https://doi.org/10.1093/eurheartj/ehv532
Pokorney, Sean D, et al. "Assessing generalizability of trial results in general practice." European heart journal vol. 37,14 (2016): 1154-7. doi: https://doi.org/10.1093/eurheartj/ehv532
Pokorney SD, O'Brien EC, Granger CB. Assessing generalizability of trial results in general practice. Eur Heart J. 2016 Apr 07;37(14):1154-7. doi: 10.1093/eurheartj/ehv532. Epub 2015 Oct 29. PMID: 26516173.
Copy Download .nbib Format: NLM
Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy .

Frontiers in immunology

Olvera A, Martinez JP, Casadellà M, Llano A, Rosás M, Mothe B, Ruiz-Riol M, Arsequell G, Valencia G, Noguera-Julian M, Paredes R, Meyerhans A, Brander C.
PMID: 29472913
Front Immunol. 2018 Jan 26;8:2010. doi: 10.3389/fimmu.2017.02010. eCollection 2017.

Glycosylation of host and viral proteins is an important posttranslational modification needed to ensure correct function of glycoproteins. For this reason, we asked whether inhibition of O-glycosylation during human immunodeficiency virus (HIV)

Cite
Olvera A, Martinez JP, Casadellà M, et al. Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy . Front Immunol. 2018;8:2010doi: 10.3389/fimmu.2017.02010.
Olvera, A., Martinez, J. P., Casadellà, M., Llano, A., Rosás, M., Mothe, B., Ruiz-Riol, M., Arsequell, G., Valencia, G., Noguera-Julian, M., Paredes, R., Meyerhans, A., & Brander, C. (2017). Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy . Frontiers in immunology, 82010. https://doi.org/10.3389/fimmu.2017.02010
Olvera, Alex, et al. "Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy ." Frontiers in immunology vol. 8 (2017): 2010. doi: https://doi.org/10.3389/fimmu.2017.02010
Olvera A, Martinez JP, Casadellà M, Llano A, Rosás M, Mothe B, Ruiz-Riol M, Arsequell G, Valencia G, Noguera-Julian M, Paredes R, Meyerhans A, Brander C. Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy . Front Immunol. 2018 Jan 26;8:2010. doi: 10.3389/fimmu.2017.02010. eCollection 2017. PMID: 29472913; PMCID: PMC5810283.
Copy Download .nbib Format: NLM
Cleared for takeoff: The effects of hypobaric conditions on traumatic pneumothoraces.

The journal of trauma and acute care surgery

Majercik S, White TW, Van Boerum DH, Granger S, Bledsoe J, Conner K, Wilson E, Weaver LK.
PMID: 25494425
J Trauma Acute Care Surg. 2014 Nov;77(5):729-733. doi: 10.1097/TA.0000000000000441.

BACKGROUND: Current guidelines suggest that traumatic pneumothorax (tPTX) is a contraindication to commercial airline travel, and patients should wait at least 2 weeks after radiographic resolution of tPTX to fly. This recommendation is not based on prospective, physiologic study....

Cite
Majercik S, White TW, Van Boerum DH, et al. Cleared for takeoff: The effects of hypobaric conditions on traumatic pneumothoraces. J Trauma Acute Care Surg. 2014;77(5):729-733doi: 10.1097/TA.0000000000000441.
Majercik, S., White, T. W., Van Boerum, D. H., Granger, S., Bledsoe, J., Conner, K., Wilson, E., & Weaver, L. K. (2014). Cleared for takeoff: The effects of hypobaric conditions on traumatic pneumothoraces. The journal of trauma and acute care surgery, 77(5), 729-733. https://doi.org/10.1097/TA.0000000000000441
Majercik, Sarah, et al. "Cleared for takeoff: The effects of hypobaric conditions on traumatic pneumothoraces." The journal of trauma and acute care surgery vol. 77,5 (2014): 729-733. doi: https://doi.org/10.1097/TA.0000000000000441
Majercik S, White TW, Van Boerum DH, Granger S, Bledsoe J, Conner K, Wilson E, Weaver LK. Cleared for takeoff: The effects of hypobaric conditions on traumatic pneumothoraces. J Trauma Acute Care Surg. 2014 Nov;77(5):729-733. doi: 10.1097/TA.0000000000000441. PMID: 25494425.
Copy Download .nbib Format: NLM
Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease.

Arteriosclerosis, thrombosis, and vascular biology

Ghosh S, Vivar J, Nelson CP, Willenborg C, Segrè AV, Mäkinen VP, Nikpay M, Erdmann J, Blankenberg S, O'Donnell C, März W, Laaksonen R, Stewart AF, Epstein SE, Shah SH, Granger CB, Hazen SL, Kathiresan S, Reilly MP, Yang X, Quertermous T, Samani NJ, Schunkert H, Assimes TL, McPherson R.
PMID: 25977570
Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1712-22. doi: 10.1161/ATVBAHA.115.305513. Epub 2015 May 14.

OBJECTIVE: Genome-wide association studies have identified multiple genetic variants affecting the risk of coronary artery disease (CAD). However, individually these explain only a small fraction of the heritability of CAD and for most, the causal biological mechanisms remain unclear....

Cite
Ghosh S, Vivar J, Nelson CP, et al. Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2015;35(7):1712-22doi: 10.1161/ATVBAHA.115.305513.
Ghosh, S., Vivar, J., Nelson, C. P., Willenborg, C., Segrè, A. V., Mäkinen, V. P., Nikpay, M., Erdmann, J., Blankenberg, S., O'Donnell, C., März, W., Laaksonen, R., Stewart, A. F., Epstein, S. E., Shah, S. H., Granger, C. B., Hazen, S. L., Kathiresan, S., Reilly, M. P., Yang, X., Quertermous, T., Samani, N. J., Schunkert, H., Assimes, T. L., & McPherson, R. (2015). Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology, 35(7), 1712-22. https://doi.org/10.1161/ATVBAHA.115.305513
Ghosh, Sujoy, et al. "Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease." Arteriosclerosis, thrombosis, and vascular biology vol. 35,7 (2015): 1712-22. doi: https://doi.org/10.1161/ATVBAHA.115.305513
Ghosh S, Vivar J, Nelson CP, Willenborg C, Segrè AV, Mäkinen VP, Nikpay M, Erdmann J, Blankenberg S, O'Donnell C, März W, Laaksonen R, Stewart AF, Epstein SE, Shah SH, Granger CB, Hazen SL, Kathiresan S, Reilly MP, Yang X, Quertermous T, Samani NJ, Schunkert H, Assimes TL, McPherson R. Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1712-22. doi: 10.1161/ATVBAHA.115.305513. Epub 2015 May 14. PMID: 25977570; PMCID: PMC4841833.
Copy Download .nbib Format: NLM
Health Information Technology: Meaningful Use and Next Steps to Improving Electronic Facilitation of Medication Adherence.

JMIR medical informatics

Bosworth HB, Zullig LL, Mendys P, Ho M, Trygstad T, Granger C, Oakes MM, Granger BB.
PMID: 26980270
JMIR Med Inform. 2016 Mar 15;4(1):e9. doi: 10.2196/medinform.4326.

BACKGROUND: The use of health information technology (HIT) may improve medication adherence, but challenges for implementation remain.OBJECTIVE: The aim of this paper is to review the current state of HIT as it relates to medication adherence programs, acknowledge the...

Cite
Bosworth HB, Zullig LL, Mendys P, et al. Health Information Technology: Meaningful Use and Next Steps to Improving Electronic Facilitation of Medication Adherence. JMIR Med Inform. 2016;4(1):e9doi: 10.2196/medinform.4326.
Bosworth, H. B., Zullig, L. L., Mendys, P., Ho, M., Trygstad, T., Granger, C., Oakes, M. M., & Granger, B. B. (2016). Health Information Technology: Meaningful Use and Next Steps to Improving Electronic Facilitation of Medication Adherence. JMIR medical informatics, 4(1), e9. https://doi.org/10.2196/medinform.4326
Bosworth, Hayden B, et al. "Health Information Technology: Meaningful Use and Next Steps to Improving Electronic Facilitation of Medication Adherence." JMIR medical informatics vol. 4,1 (2016): e9. doi: https://doi.org/10.2196/medinform.4326
Bosworth HB, Zullig LL, Mendys P, Ho M, Trygstad T, Granger C, Oakes MM, Granger BB. Health Information Technology: Meaningful Use and Next Steps to Improving Electronic Facilitation of Medication Adherence. JMIR Med Inform. 2016 Mar 15;4(1):e9. doi: 10.2196/medinform.4326. PMID: 26980270; PMCID: PMC4812045.
Copy Download .nbib Format: NLM
Reaction Pathways Involved in CH4 Conversion on Pd/Al2O3 Catalysts: TAP as a Powerful Tool for the Elucidation of the Effective Role of the Metal/Support Interface.

Frontiers in chemistry

Renème Y, Pietrzyk S, Dhainaut F, Chaar M, van Veen AC, Granger P.
PMID: 26909345
Front Chem. 2016 Feb 16;4:7. doi: 10.3389/fchem.2016.00007. eCollection 2016.

Temporal Analysis of Products (TAP) investigation on Natural Gas-fueled Vehicle (NGV) catalysts provides information related to the nature of reaction steps involved over noble metals and at the metal-support interface. The determination of accurate kinetic parameters for methane adsorption...

Cite
Renème Y, Pietrzyk S, Dhainaut F, et al. Reaction Pathways Involved in CH4 Conversion on Pd/Al2O3 Catalysts: TAP as a Powerful Tool for the Elucidation of the Effective Role of the Metal/Support Interface. Front Chem. 2016;4:7doi: 10.3389/fchem.2016.00007.
Renème, Y., Pietrzyk, S., Dhainaut, F., Chaar, M., van Veen, A. C., & Granger, P. (2016). Reaction Pathways Involved in CH4 Conversion on Pd/Al2O3 Catalysts: TAP as a Powerful Tool for the Elucidation of the Effective Role of the Metal/Support Interface. Frontiers in chemistry, 47. https://doi.org/10.3389/fchem.2016.00007
Renème, Y, et al. "Reaction Pathways Involved in CH4 Conversion on Pd/Al2O3 Catalysts: TAP as a Powerful Tool for the Elucidation of the Effective Role of the Metal/Support Interface." Frontiers in chemistry vol. 4 (2016): 7. doi: https://doi.org/10.3389/fchem.2016.00007
Renème Y, Pietrzyk S, Dhainaut F, Chaar M, van Veen AC, Granger P. Reaction Pathways Involved in CH4 Conversion on Pd/Al2O3 Catalysts: TAP as a Powerful Tool for the Elucidation of the Effective Role of the Metal/Support Interface. Front Chem. 2016 Feb 16;4:7. doi: 10.3389/fchem.2016.00007. eCollection 2016. PMID: 26909345; PMCID: PMC4754408.
Copy Download .nbib Format: NLM
Effect of template ion-ligand complex stoichiometry on selectivity of ion-imprinted polymers.

Talanta

Laatikainen K, Udomsap D, Siren H, Brisset H, Sainio T, Branger C.
PMID: 25618705
Talanta. 2015 Mar;134:538-545. doi: 10.1016/j.talanta.2014.11.050. Epub 2014 Dec 08.

In order to highlight the importance of the complex stoichiometry during ion imprinted polymer (IIP) synthesis, we investigated the effect of the complex structure on IIPs selectivity by adjusting the complex stoichiometry before polymerization. 2-(aminomethyl)pyridine monomer (amp) was chosen...

Cite
Laatikainen K, Udomsap D, Siren H, et al. Effect of template ion-ligand complex stoichiometry on selectivity of ion-imprinted polymers. Talanta. 2014;134:538-545doi: 10.1016/j.talanta.2014.11.050.
Laatikainen, K., Udomsap, D., Siren, H., Brisset, H., Sainio, T., & Branger, C. (2015). Effect of template ion-ligand complex stoichiometry on selectivity of ion-imprinted polymers. Talanta, 134538-545. https://doi.org/10.1016/j.talanta.2014.11.050
Laatikainen, Katri, et al. "Effect of template ion-ligand complex stoichiometry on selectivity of ion-imprinted polymers." Talanta vol. 134 (2015): 538-545. doi: https://doi.org/10.1016/j.talanta.2014.11.050
Laatikainen K, Udomsap D, Siren H, Brisset H, Sainio T, Branger C. Effect of template ion-ligand complex stoichiometry on selectivity of ion-imprinted polymers. Talanta. 2015 Mar;134:538-545. doi: 10.1016/j.talanta.2014.11.050. Epub 2014 Dec 08. PMID: 25618705.
Copy Download .nbib Format: NLM
Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma.

Oncoimmunology

Combe P, de Guillebon E, Thibault C, Granier C, Tartour E, Oudard S.
PMID: 26155388
Oncoimmunology. 2015 Mar 19;4(5):e1001236. doi: 10.1080/2162402X.2014.1001236. eCollection 2015 May.

Despite the renaissance of cancer immunotherapy, no novel immunotherapy has been approved for the treatment of renal cell cancer (RCC) since the availability of recombinant cytokines (interleukin-2, interferon-α). All vaccine trials have failed to meet their endpoints although they...

Cite
Combe P, de Guillebon E, Thibault C, et al. Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma. Oncoimmunology. 2015;4(5):e1001236doi: 10.1080/2162402X.2014.1001236.
Combe, P., de Guillebon, E., Thibault, C., Granier, C., Tartour, E., & Oudard, S. (2015). Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma. Oncoimmunology, 4(5), e1001236. https://doi.org/10.1080/2162402X.2014.1001236
Combe, Pierre, et al. "Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma." Oncoimmunology vol. 4,5 (2015): e1001236. doi: https://doi.org/10.1080/2162402X.2014.1001236
Combe P, de Guillebon E, Thibault C, Granier C, Tartour E, Oudard S. Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma. Oncoimmunology. 2015 Mar 19;4(5):e1001236. doi: 10.1080/2162402X.2014.1001236. eCollection 2015 May. PMID: 26155388; PMCID: PMC4485845.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 562 entries